165 related articles for article (PubMed ID: 21784465)
21. Surgical consolidation of initially unresectable urothelial carcinoma: an incremental opportunity to cure.
Siefker-Radtke AO
Expert Rev Anticancer Ther; 2009 Dec; 9(12):1701-3. PubMed ID: 19954279
[No Abstract] [Full Text] [Related]
22. Re: Markus J. Bader, Ronald Sroka, Christian Gratzke, et al. Laser therapy for upper urinary tract transitional cell carcinoma: indications and management. Eur Urol 2009;56:65-71.
Palou J; Rodríguez Ó; Breda A
Eur Urol; 2010 Apr; 57(4):e31-2; author reply e33. PubMed ID: 20006423
[No Abstract] [Full Text] [Related]
23. Re: Markus J. Bader, Ronald Sroka, Christian Gratzke, et al. Laser therapy for upper urinary tract transitional cell carcinoma: indications and management. Eur Urol 2009;56:65-71.
Matera L
Eur Urol; 2009 Nov; 56(5):e30; author reply e31. PubMed ID: 19665288
[No Abstract] [Full Text] [Related]
24. Feasibility of conservative surgery for transitional cell cancer of the upper urinary tract.
Zincke H; Neves RJ
Urol Clin North Am; 1984 Nov; 11(4):717-24. PubMed ID: 6506376
[TBL] [Abstract][Full Text] [Related]
25. Use of cytomorphometry and cytology in the diagnosis of transitional-cell carcinoma of the upper urinary tract.
Seldenrijk CA; Verheggen WJ; Veldhuizen RW; Blok AP; Ooms EC
Acta Cytol; 1987; 31(2):137-42. PubMed ID: 3469846
[TBL] [Abstract][Full Text] [Related]
26. Micropapillary variant of urothelial carcinoma of the urinary bladder; a clinicopathological and immunohistochemical study.
Samaratunga H; Khoo K
Histopathology; 2004 Jul; 45(1):55-64. PubMed ID: 15228444
[TBL] [Abstract][Full Text] [Related]
27. Promoter hypermethylation is associated with tumor location, stage, and subsequent progression in transitional cell carcinoma.
Catto JW; Azzouzi AR; Rehman I; Feeley KM; Cross SS; Amira N; Fromont G; Sibony M; Cussenot O; Meuth M; Hamdy FC
J Clin Oncol; 2005 May; 23(13):2903-10. PubMed ID: 15753461
[TBL] [Abstract][Full Text] [Related]
28. [Tumor markers in the histopathology of urologic tumors].
Hofstädter F
Urologe A; 1987 Jan; 26(1):2-6. PubMed ID: 3576859
[TBL] [Abstract][Full Text] [Related]
29. Urine cytology of transitional cell neoplasms.
Rife CC; Farrow GM; Utz DC
Urol Clin North Am; 1979 Oct; 6(3):599-612. PubMed ID: 505675
[TBL] [Abstract][Full Text] [Related]
30. Diagnostic accuracy and key cytologic features of high-grade transitional cell carcinoma in the upper urinary tract.
Potts SA; Thomas PA; Cohen MB; Raab SS
Mod Pathol; 1997 Jul; 10(7):657-62. PubMed ID: 9237174
[TBL] [Abstract][Full Text] [Related]
31. Lymphovascular invasion is independently associated with poor prognosis in patients with localized upper urinary tract urothelial carcinoma treated surgically.
Saito K; Kawakami S; Fujii Y; Sakura M; Masuda H; Kihara K
J Urol; 2007 Dec; 178(6):2291-6; discussion 2296. PubMed ID: 17936818
[TBL] [Abstract][Full Text] [Related]
32. Urinary nuclear matrix protein as a marker for transitional cell carcinoma of the urinary tract.
Carpinito GA; Stadler WM; Briggman JV; Chodak GW; Church PA; Lamm DL; Lange PH; Messing EM; Pasciak RM; Reservitz GB; Ross RN; Rukstalis DB; Sarosdy MF; Soloway MS; Thiel RP; Vogelzang N; Hayden CL
J Urol; 1996 Oct; 156(4):1280-5. PubMed ID: 8808854
[TBL] [Abstract][Full Text] [Related]
33. Placental S100 (S100P) and GATA3: markers for transitional epithelium and urothelial carcinoma discovered by complementary DNA microarray.
Higgins JP; Kaygusuz G; Wang L; Montgomery K; Mason V; Zhu SX; Marinelli RJ; Presti JC; van de Rijn M; Brooks JD
Am J Surg Pathol; 2007 May; 31(5):673-80. PubMed ID: 17460449
[TBL] [Abstract][Full Text] [Related]
34. Concomitant carcinoma in situ and tumour size are prognostic factors for bladder recurrence after nephroureterectomy for upper tract transitional cell carcinoma.
Pieras E; Frontera G; Ruiz X; Vicens A; Ozonas M; Pizá P
BJU Int; 2010 Nov; 106(9):1319-23. PubMed ID: 20394618
[TBL] [Abstract][Full Text] [Related]
35. Renal safety and efficacy of cisplatin-based chemotherapy in patients with a solitary kidney after nephroureterectomy for urothelial carcinoma of the upper urinary tract.
Cho KS; Joung JY; Seo HK; Cho IC; Chung HS; Chung J; Lee KH
Cancer Chemother Pharmacol; 2011 Apr; 67(4):769-74. PubMed ID: 20532510
[TBL] [Abstract][Full Text] [Related]
36. [Urinary cytology of transitional-cell carcinoma].
Piazza G; Galia A; Cosentino A; Grasso G
Pathologica; 1995 Apr; 87(2):146-7. PubMed ID: 8532407
[TBL] [Abstract][Full Text] [Related]
37. Transitional cell carcinoma of the upper uroepithelial tract.
Michaelson MD; Kaufman DS; Oh WK
Clin Adv Hematol Oncol; 2003 Feb; 1(2):102-4; discussion 105. PubMed ID: 16224387
[No Abstract] [Full Text] [Related]
38. Cutaneous metastasis of micropapillary urothelial carcinoma.
Truong H; Parsons TM; Trabulsi EJ
Urology; 2015 Feb; 85(2):e7-8. PubMed ID: 25559725
[TBL] [Abstract][Full Text] [Related]
39. Expression of hypoxia-inducible factor-1alpha protein predicts survival in patients with transitional cell carcinoma of the upper urinary tract.
Nakanishi K; Hiroi S; Tominaga S; Aida S; Kasamatsu H; Matsuyama S; Matsuyama T; Kawai T
Clin Cancer Res; 2005 Apr; 11(7):2583-90. PubMed ID: 15814637
[TBL] [Abstract][Full Text] [Related]
40. Prognostic impact of p63 and p53 expression in upper urinary tract transitional cell carcinoma.
Zigeuner R; Tsybrovskyy O; Ratschek M; Rehak P; Lipsky K; Langner C
Urology; 2004 Jun; 63(6):1079-83. PubMed ID: 15183954
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
